| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 17 | 19 | 21 | 32 | 25 | 30 | 38 | 32 | 37 | 39 | 37 | 50 | 48 | 51 | 54 | 56 | 61 | 75 | 93 | 105 | 117 | 137 | 142 | 138 | 134 | 174 | 163 | 1,314 | 161 | 197 | 260 | 285 | 322 | 348 | 368 | 395 | 325 | 299 | 296 | 270 | 308 | 324 |
| Expenses | 22 | 23 | 28 | 38 | 35 | 36 | 41 | 38 | 41 | 44 | 39 | 45 | 52 | 56 | 60 | 65 | 75 | 89 | 105 | 116 | 132 | 137 | 144 | 141 | 141 | 178 | 169 | 156 | 194 | 222 | 269 | 291 | 324 | 327 | 355 | 371 | 317 | 273 | 468 | 307 | 311 | 292 |
| EBITDA | -6 | -4 | -7 | -5 | -10 | -6 | -3 | -5 | -4 | -5 | -2 | 5 | -4 | -5 | -7 | -8 | -14 | -14 | -12 | -11 | -15 | 0 | -2 | -2 | -7 | -4 | -6 | 1,158 | -33 | -25 | -8 | -6 | -3 | 21 | 13 | 24 | 8 | 26 | -172 | -38 | -3 | 31 |
| Operating Profit % | -43 % | -27 % | -37 % | -18 % | -43 % | -23 % | -9 % | -18 % | -19 % | -14 % | -8 % | -3 % | -11 % | -13 % | -13 % | -19 % | -24 % | -19 % | -13 % | -12 % | -14 % | -0 % | -2 % | -2 % | -6 % | -3 % | -6 % | -9 % | -24 % | -16 % | -6 % | -4 % | -4 % | 3 % | 1 % | 1 % | -3 % | -1 % | -71 % | -9 % | -9 % | 2 % |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -8 | -6 | -9 | -8 | -13 | -8 | -5 | -8 | -7 | -7 | -4 | 3 | -5 | -7 | -9 | -11 | -16 | -16 | -14 | -12 | -16 | -1 | -3 | -4 | -9 | -6 | -8 | 1,157 | -34 | -26 | -11 | -9 | -6 | 19 | 11 | 21 | 5 | 25 | -174 | -39 | -5 | 30 |
| Tax | -1 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | -5 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 1 | 1 | 133 | -8 | -1 | -8 | 18 | 42 | 19 | 23 | 24 | -17 | -16 | -19 | -1 | -22 | 4 |
| Net Profit | -6 | -6 | -9 | -8 | -12 | -9 | -5 | -8 | -7 | -7 | -4 | 2 | -5 | -7 | -9 | -11 | -16 | -10 | -14 | -12 | -15 | -1 | -4 | -4 | -9 | -6 | -9 | 1,024 | -26 | -25 | -3 | -26 | -48 | -0 | -12 | -3 | 22 | 41 | -155 | -38 | 18 | 27 |
| EPS in ₹ | -1.96 | -1.91 | -2.83 | -2.43 | -3.80 | -2.69 | -1.67 | -2.43 | -2.24 | -2.20 | -0.97 | -0.68 | -1.33 | -1.92 | -2.47 | -3.02 | -4.39 | -2.62 | -3.82 | -2.69 | -3.06 | -0.04 | -0.70 | -0.63 | -1.90 | -1.14 | -1.43 | 232.31 | -6.07 | -6.24 | -0.39 | -6.00 | -10.75 | 0.41 | -2.55 | -0.23 | 5.17 | 9.79 | -34.40 | -8.47 | 4.30 | 7.52 |
Sastasundar Ventures
Sastasundar Ventures
305.30
-4.70
(-1.52%)
Key Fundamentals
Market Cap
986.10 Cr
EPS
-28.66
PE Ratio
-6.49
Dividend Yield
0.00 %
Industry
Healthcare Services 52 Week High
381.70
52 Week Low
205.00
PB Ratio
1.44
Debt to Equity
0.00
Sector
Healthcare Service Provider Actual
Company News
View All News
Sastasundar Healthbuddy Limited, a material subsidiary of Sastasundar Ventures Limited, has approved a buyback of 20,27,534 equity shares at Rs 493.21 per share, totaling Rs 1,00,00,00,044. The buyback requires shareholder approval from Sastasundar Healthbuddy Limited. The board of directors approved this proposal at their meeting held on September 19, 2025. The trading window for company securities will remain closed for designated persons until September 23, 2025.
SastaSundar Ventures Reports Mixed Q1 FY26 Results with B2B Growth Offsetting B2C Decline
Aug 16, 2025
Aug 16, 2025SastaSundar Ventures Limited, a healthcare digital platform operator, reported total revenue of ₹298.4 crores in Q1 FY26, with overall revenue growing 5.9% year-over-year to ₹278.5 crores. The company's B2B segment RetailerShakti drove growth with revenue increasing 30.9% to ₹244.5 crores, while the B2C SastaSundar segment declined significantly by 55.7% to ₹33.3 crores. Financial Services showed strong growth of 168.9% to ₹19.9 crores. Despite revenue growth, profitability remained challenging with EBITDA at -₹13.8 crores compared to -₹9.7 crores in the previous year, though PAT was positive at ₹26.6 crores, down 35.1% year-over-year. The company maintains a strong balance sheet with total assets of ₹974.4 crores and ₹655 crores in liquid assets, though operating cash flow was negative at -₹17.3 crores for FY25. Working capital management improved with inventory days reducing from 40 to 36 days.
Sastasundar Ventures Limited reported unaudited financial results for the quarter ended June 30, 2025. On a standalone basis, the company recorded a net loss of Rs. 10.95 lakhs compared to Rs. 22.15 lakhs loss in the same quarter last year. Revenue from operations stood at Rs. 9.67 lakhs. On a consolidated basis, the company reported a net profit of Rs. 2,659.21 lakhs for the quarter, with total revenue from operations at Rs. 29,842.82 lakhs. The consolidated results include contributions from subsidiaries across Financial Services and Healthcare Network segments. The company operates as a Core Investment Company with business segments in financial services and healthcare network operations.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,108.10 | #1 26,445.40 | 50.26 | #1 2,554.80 | 11.28 | #1 492 | 24.30 | 43.79 | |
992.05 | 10,295.10 | 67.60 | 699.70 | 23.06 | 144 | 22.54 | 42.12 | |
1,938.20 | 10,103.00 | 65.93 | 1,346.30 | 10.64 | 146 | 18.90 | 38.21 | |
1,243.90 | 6,760.50 | 52.12 | 702.20 | 20.80 | 91 | 81.06 | 51.86 | |
779.10 | 2,643.10 | 31.52 | 742.70 | 16.70 | 78 | 14.53 | 40.44 | |
300.55 | 1,563.20 | 48.21 | 255.90 | 15.11 | 31 | 19.48 | 49.29 | |
1,378.00 | 1,176.60 | 24.27 | 111.60 | 28.72 | 48 | 11.50 | 43.85 | |
305.30 | #8 986.10 | #1 -6.49 | #3 1,170.80 | #10 -18.47 | #10 -134 | #9 -35.12 | 49.51 | |
261.00 | 503.60 | 19.21 | 147.80 | #1 134.60 | 19 | #1 444.44 | 44.37 | |
163.30 | 117.60 | 76.21 | 41.80 | 13.28 | 2 | 0.00 | 31.57 |
Growth Rate
Revenue Growth
-18.47 %
Net Income Growth
-2,362.71 %
Cash Flow Change
-148.27 %
ROE
-2,718.64 %
ROCE
750.91 %
EBITDA Margin (Avg.)
-92.79 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 281 | 256 | 251 | 236 | 231 | 316 | 293 | 1,278 | 1,206 | 1,150 | 974 |
| Fixed Assets | 138 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 |
| Current Assets | 88 | 90 | 108 | 95 | 66 | 137 | 131 | 508 | 575 | 354 | 267 |
| Capital Work in Progress | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 |
| Investments | 4 | 1 | 8 | 28 | 36 | 56 | 43 | 666 | 513 | 676 | 575 |
| Other Assets | 137 | 129 | 119 | 89 | 77 | 146 | 139 | 518 | 585 | 363 | 287 |
| Total Liabilities | 281 | 256 | 251 | 236 | 231 | 316 | 293 | 1,278 | 1,206 | 1,150 | 974 |
| Current Liabilities | 22 | 31 | 49 | 27 | 22 | 66 | 60 | 68 | 110 | 79 | 105 |
| Non Current Liabilities | 4 | 7 | 7 | 5 | 8 | 3 | 3 | 116 | 102 | 72 | 5 |
| Total Equity | 255 | 218 | 195 | 203 | 200 | 246 | 229 | 1,094 | 994 | 1,000 | 865 |
| Reserve & Surplus | 223 | 186 | 158 | 144 | 106 | 173 | 163 | 790 | 717 | 726 | 638 |
| Share Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | -0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 | -0 | -19 |
| Investing Activities | 7 | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 133 | -34 | -1 |
| Operating Activities | -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 36 | -17 |
| Financing Activities | 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | -0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 74.43 % | 74.43 % | 74.43 % | 73.72 % | 73.72 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.94 % | 74.11 % | 74.24 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.32 % | 0.49 % | 0.56 % | 0.61 % | 0.99 % | 1.71 % | 1.60 % | 1.88 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.09 % | 0.09 % | 0.09 % | 0.17 % | 0.17 % | 0.86 % | 0.96 % | 1.35 % | 1.98 % | 1.85 % | 2.06 % | 2.09 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 11.41 % | 13.05 % | 13.03 % | 13.80 % | 14.49 % | 14.70 % | 15.01 % | 15.24 % | 15.09 % | 15.17 % | 15.64 % | 16.52 % | 16.06 % | 15.05 % | 14.47 % | 14.09 % | 13.70 % | 13.35 % |
| Others | 14.16 % | 12.52 % | 12.55 % | 12.48 % | 11.79 % | 11.38 % | 10.98 % | 10.76 % | 10.90 % | 10.74 % | 9.95 % | 8.20 % | 8.51 % | 9.07 % | 8.63 % | 8.41 % | 8.52 % | 8.44 % |
| No of Share Holders | 11,797 | 13,034 | 13,090 | 14,276 | 15,174 | 15,247 | 15,554 | 15,166 | 15,088 | 14,752 | 14,633 | 14,053 | 14,544 | 14,493 | 15,360 | 14,093 | 13,693 | 13,452 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 27 Sept 2016 |  Change Of Name | NA | 27 Sept 2016 | 0.00 | 0.00 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 307.85 | 306.85 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 335.25 | 318.20 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 282.35 | 275.90 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 270.00 | 265.95 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 285.15 | 293.25 |
| 26 Sept 2025 | Annual General Meeting | NA | 26 Sept 2025 | 271.55 | 307.40 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20186 days ago
6 days agoDisclosure Under Reg 30 Of SEBI (LODR) Reg 2015 - Update On The Buy-Back Proposal By Sastasundar Healthbuddy Limited Unlisted Material Subsidiary Of The CompanySep 30, 2025
Sep 30, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Sep 27, 2025Disclosure Of Voting Results In Terms Of Regulation 44 Of SEBI (LODR) Reg 2015 And Revised ScrutinizerS Report Of 36Th AGMSep 27, 2025
Sep 27, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2025
Sep 26, 2025Closure of Trading WindowSep 19, 2025
Sep 19, 2025Disclosure Under Reg 30 Of SEBI (LODR) Reg 2015 - Buy-Back Proposal By Sastasundar Healthbuddy Limited Material Subsidiary Of The CompanySep 19, 2025
Sep 19, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Disclosure Under Reg 30 Of SEBI (LODR) - Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With The Company Or RTA Or Depository ParticipantsSep 02, 2025
Sep 02, 2025Business Responsibility and Sustainability Reporting (BRSR)Sep 02, 2025
Sep 02, 2025Reg. 34 (1) Annual Report.Sep 02, 2025
Sep 02, 2025Notice Of The 36Th Annual General Meeting Of The CompanySep 02, 2025
Sep 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Aug 30, 2025Intimation Regarding Annual General Meeting And Book ClosureAug 29, 2025
Aug 29, 2025Intimation Regarding Annual General Meeting And Book ClosureAug 29, 2025
Aug 29, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 19, 2025
Aug 19, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotAug 19, 2025
Aug 19, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 16, 2025
Aug 16, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Aug 13, 2025Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive InformationAug 12, 2025
Aug 12, 2025Results - Unaudited Financial Results Standalone And Consolidated For The Quarter Ended 30Th June 2025Aug 12, 2025
Aug 12, 2025Board Meeting Outcome for Outcome Of Board Meeting Held Today The 12Th August 2025Aug 12, 2025
Aug 12, 2025Update On Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Aug 06, 2025
Aug 06, 2025Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2025Aug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2025
Jul 18, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotJul 17, 2025
Jul 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 19, 2025
Jun 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 12, 2025
Jun 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2025
Jun 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 05, 2025
Jun 05, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJun 02, 2025
Jun 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 01, 2025
Jun 01, 2025Disclosure Under Reg 30 Of SEBI LODR - Completion Of Transaction For Sale Of Stake Of Step Down SubsidiaryMay 31, 2025
May 31, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2025
May 30, 2025Results - Audited Financial Results As On 31St March 2025May 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th May 2025May 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Disclosure Under Regulation 30 Of SEBI (LODR) Reg 2015 - Registrar Of Companies Adjudication OrderMay 23, 2025
May 23, 2025Board Meeting Intimation for To Consider And Approve The Audited Financial Results For The Quarter And Financial Year Ended 31St March 2025May 22, 2025
May 22, 2025Intimation Of Reduction Of Share Capital Of Step-Down Subsidiary Of The CompanyMay 02, 2025
May 02, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Apr 09, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 03, 2025
Apr 03, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Apr 02, 2025
Apr 02, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Mar 29, 2025
Mar 29, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Mar 12, 2025
Mar 12, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.02% | -3 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 49.51
ATR(14)
Volatile 13.72
STOCH(9,6)
Neutral 31.10
STOCH RSI(14)
Neutral 20.53
MACD(12,26)
Bearish -1.69
ADX(14)
Strong Trend 32.90
UO(9)
Bearish 41.46
ROC(12)
Uptrend And Accelerating 0.08
WillR(14)
Neutral -73.34
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
